Inventor

LABRIE FERNAND

CA97 patents

⚠️ This page may combine multiple inventors who share the name “LABRIE FERNAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LABRIE FERNAND

ENDORECHERCHE INC

Anti-estrogenic compounds and compositions

Controlled release systems and low dose androgens

Controlled release systems and low dose androgens

Controlled release systems and low dose androgens

Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds

Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone

Low dose androgenic compounds for prevention and treatment of endometriosis

Method of treatment of androgen-related diseases

Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia

Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds

Combination therapy for the treatment of estrogen-sensitive disease

Therapeutic antiestrogens

Method of treatment of androgen-related diseases

Controlled release systems and low dose androgens

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Method and treatment of androgen-related diseases

Activation of androgen receptors with low dose non-masculinizing androgenic compounds

Androgen derivatives for use in the inhibition of sex steroid activity

Benzopyran-containing compounds and method for their use

Sex steroid activity inhibitors

Sex steroid activity inhibitors

Aromatase inhibitors

Estrogen nucleus derivatives for use in inhibition of sex steroid activity

ENDORECH INC

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Therapeutic methods and delivery systems utilizing sex steroid precursors

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Uses for androst-5-ene-3β, 17β-diol

Methods of treating and/or suppressing weight gain

Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use

LABRIE FERNAND

Pharmaceutical compositions

Combination therapy for treatment of female breast cancer

Combination therapy for selected sex steroid dependent cancers

Combination therapy for treatment of female breast cancer

Method of treatment of prostate cancer

Treatment of breast cancer by combination therapy

Combination male breast cancer therapy

ROUSSEL UCLAF

Treatment method

ENDORECHERCHE

Inhibitors of sex steroid biosynthesis and methods for their production and use